Abstract: Objective To understand the current situation of health resources allocation, covering human resources, equipment allocation and pharmaceutical setting for the prevention and treatment of chronic respiratory diseases in primary medical institutes in Weifang. Methods The questionnaire survey was conducted among 19 secondary hospitals, 48 community health service centers/township hospitals and 413 community health service stations/village clinics, investigating the person in charge and using stratified cluster sampling method, from December, 2015 to January, 2016 in Weifang. Results ① In terms of health manpower, in secondary hospitals, community health service centers/township hospitals and community health service stations/village clinics, workers are mainly with primary title, accounting for 43.5%, 50.2% and 63.6% respectively, who in second hospitals 41.6% are mainly with college degree, and in other institutes mainly with high school degree or below, accounting for 44.2% and 86.2%. ② In terms of the equipment for the treatment of chronic respiratory diseases, the distribution rate of respiratory function instruments are 73.7%, 4.6% and 1.0% respectively in secondary hospitals, community health service centers/township hospitals and community health service stations/village clinics, the peak flow meters are only in secondary hospitals, allocation rate is 31.6%, community health service centers/township hospitals and community health service stations/village clinics have no peak flow meters. ③In terms of the drugs for the chronic respiratory diseases therapy, in secondary hospitals, community health service centers/township hospitals and community health service stations/village clinics, the distribution rate of inhaled long-acting beta 2-agonists are 73.7%, 18.8% and 14.5%, and the distribution rate of anticholinergics are 78.9%, 10.4% and 6.8%. Conclusion Primary medical institutes in Weifang are currently lack of respiratory function instruments, peak flow meters and drugs for long management of chronic respiratory diseases, for instance, inhaled long-acting beta 2-agonists and anticholinergics, so the coverage of mini respiratory function instruments, mini peak flow meters and inhaled long-acting drugs should be expanded, and the training of knowledge about prevention and treatment of the chronic respiratory diseases and pulmonary function testing operations aimed to primary medical institutes doctors should be strengthened.